Litigation Watch: ARTHRITIS DRUGS is a monthly newsletter for attorneys, focusing on drugs used to treat osteo and rheumatoid arthritis: Arava, Enbrel, Remicade, Humira, Vioxx, Celebrex and more. These drugs are already the subject of litigation following claims that they cause everything from liver damage to cancer, heart failure and strokes. Each issue features case news, interviews, legislative and FDA updates, and reviews from current medical literature.
Arthritis Drugs - Issue: 26
Merck Says Calif. Plaintiffs' Health Risk Evidence Lacks Scientific Support
Arthritis Drugs - Issue: 25
Arthritis Drugs in the Medical Literature This Month - June 2006
Merck Says Recent Discovery Precludes Efficiency of Joint Calif. Vioxx Trial
Judge: 'Residency' not Equivalent to 'Citizenship' in Pleading Diversity
Merck: Engineers Decision Immaterial to Pending Vioxx MDL Class Actions
Merck Says Vioxx MDL Court Can't Subpoena Pa. Executive for Trials
Parties Oppose Dismissal Motions Ahead of Calif. Vioxx Trial
Amgen to Pay Mass. General Hospital $186M to Settle Enbrel Royalty Dispute
